Toward a Multidimensional Framework for Defining Remission in Atopic Dermatitis.

Area of Science:

• Dermatology
• Clinical Trials
• Immunology

Background:

• Defining remission in atopic dermatitis (AD) is challenging due to inconsistent criteria and endpoints.
• Current methods often confuse disease control with true remission and lack multidomain assessments.

Purpose of the Study:

• To propose a functional spectrum of treatment response in AD, ranging from nonresponse to complete treatment-free remission.
• To integrate clinical, patient-reported, and immunological dimensions for a comprehensive assessment.
• To enhance the practical applicability of remission definitions for clinical trial design.

Main Methods:

• Review of current approaches to defining remission in atopic dermatitis.
• Proposal of a novel framework for a functional spectrum of treatment response.
• Consideration of multidomain assessments including clinical, patient-reported, and immunological factors.

Main Results:

• A proposed spectrum distinguishing complete control on therapy, durable control, response after dose tapering, and sustained improvement after treatment cessation.
• Emphasis on incorporating duration and treatment context into remission definitions.
• Identification of innovative tools like wearables and digital patient-reported outcomes for real-time disease monitoring.

Conclusions:

• Standardized remission criteria are crucial for improving cross-study comparability and guiding therapeutic development in AD.
• Adopting composite endpoints informed by disease biology and patient experience will yield more accurate and meaningful outcomes.
• The proposed framework aims to align clinical care with the goal of achieving long-term, treatment-free disease control in atopic dermatitis.